RAPP
Rapport Therapeutics, Inc.
39.39
2 x 29.52
2 x 50.86
bid
ask
-
2.28
5.47%
2 @ 04:00 PM
38.94 -0.45 (1.14%)
| Ytd | 29.83% | |
| 1y | 248.28% |
39.26
day range
41.99
11.71
52 week range
43.76
| Open | 41.40 | Prev Close | 41.67 | Low | 39.26 | High | 41.99 | Mkt Cap | 1.88B |
| Vol | 296.94K | Avg Vol | 358.11K | EPS | -2.60 | P/E | N/A | Forward P/E | -8.96 |
| Beta | 0.98 | Short Ratio | 7.43 | Inst. Own | 109.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 37.22 | 200-d Avg | 30.63 | 1yr Est | 56.64 |
| Income Statement | |||
| Total Revenue | 20.00M | ||
| Revenues (USD) | 20.00M | ||
| Gross Profit | 20.00M | ||
| Operating Expenses | 44.22M | ||
| Research and Development Expense | 32.72M | ||
| Selling, General and Administrative Expense | 11.50M | ||
| Operating Income | -24.21M | ||
| Net Income | -19.86M | ||
| Net Income Common Stock | -19.86M | ||
| Net Income Common Stock (USD) | -19.86M | ||
| Consolidated Income | -19.86M | ||
| Earnings per Basic Share | -0.42 | ||
| Earnings per Basic Share (USD) | -0.42 | ||
| Earnings per Diluted Share | -0.42 | ||
| Earning Before Interest & Taxes (EBIT) | -19.86M | ||
| Earning Before Interest & Taxes (USD) | -19.86M | ||
| Weighted Average Shares | 47.24M | ||
| Weighted Average Shares Diluted | 47.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 78.16M | ||
| Cash and Equivalents (USD) | 78.16M | ||
| Investments | 398.73M | ||
| Investments Current | 398.73M | ||
| Trade and Non-Trade Receivables | 58.00K | ||
| Current Assets | 484.70M | ||
| Property, Plant & Equipment Net | 11.85M | ||
| Total Assets | 497.60M | ||
| Debt Current | 2.62M | ||
| Total Debt | 10.80M | ||
| Current Liabilities | 17.90M | ||
| Debt Non-Current | 8.19M | ||
| Total Liabilities | 26.09M | ||
| Accumulated Retained Earnings (Deficit) | -255.08M | ||
| Accumulated Other Comprehensive Income | -505.00K | ||
| Shareholders Equity | 471.51M | ||
| Shareholders Equity (USD) | 471.51M | ||
| Assets Non-Current | 12.90M | ||
| Total Debt (USD) | 10.80M | ||
| Liabilities Non-Current | 8.19M | ||
| Trade and Non-Trade Payables | 6.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 809.00K | ||
| Net Cash Flow from Financing | 531.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.41M | ||
| Capital Expenditure | -86.00K | ||
| Issuance (Purchase) of Equity Shares | 804.00K | ||
| Net Cash Flow from Investing | 37.94M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 38.03M | ||
| Net Cash Flow from Operations | -13.06M | ||
| Share Based Compensation | 6.96M | ||